Clinical Study

Logo PR Newswire
HealthPress Release2023-03-31 18:45:00
DUBLIN, March 31, 2023 /PRNewswire/ -- The "Sleep Disorders Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In...

Logo EIN Presswire
HealthPress Release2023-03-31 17:34:25
Restriction: None Free Use For All Associated Press Content Services/Rensselaer Polytechnic Institute We are moving away from the old theories and concepts...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-31 16:45:00
Foundational LCD, to be effective May 14, 2023, incorporates key feedback to 2022 draft, including updated guidelines recommending non-endoscopic biomarker...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-31 14:00:00
Scribe Therapeutics Inc., a molecular engineering company enabling the creation of genetic medicines through its CRISPR by Design approach to genetic...

Logo GlobeNewswire
SciencePress Release2023-03-31 23:03:00
12-month interim data from the ongoing 2-year, Phase 2 Stargardt disease (STGD1) study continues to show halting or slowing of lesion growth; 18-month...

Logo PR Newswire
HealthPress Release2023-03-31 14:30:00
DUBLIN, March 31, 2023 /PRNewswire/ -- The "Physician Office In Vitro Diagnostic (IVD) Test Markets" report has been added to ResearchAndMarkets.com's...

Logo PR Newswire
HealthPress Release2023-03-31 14:15:00
DUBLIN, March 31, 2023 /PRNewswire/ -- The "The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico,...

Logo PR Newswire
STOCKHOLM, March 31, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today the publication of additional...

Logo PR Newswire
HealthPress Release2023-03-31 16:39:00
Company Successfully Completes Phase 2a Clinical Trial Fourth Quarter or Full Year Highlights • Appointed Douglas Johnston as CFO in November 2022 •...

Logo GlobeNewswire
SciencePress Release2023-03-31 12:00:00
-- Completed business combination with FLAC and closed concurrent, oversubscribed approximately $235 million PIPE, led by Frazier Healthcare Partners and...

Logo U.S. News & World Report
PoliticsBy Health Day2023-03-31 11:41:00
By Cara Murez HealthDay Reporter FRIDAY, March 31, 2023 (HealthDay News) -- Telehealth appointments meetings with a doctor through a phone or video call are...

Logo GlobeNewswire
SciencePress Release2023-03-31 12:00:00
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...

Logo PR Newswire
HealthPress Release2023-03-31 16:45:00
Foundational LCD, to be effective May 14, 2023, incorporates key feedback to 2022 draft, including updated guidelines recommending non-endoscopic biomarker...

Logo Nasdaq
Business / FinanceBy Rtt News2023-03-31 05:22:38
(RTTNews) - Drug makers Biogen Inc. (BIIB) and Japan's Eisai Co., Ltd. (ESALY.PK, ESALF.PK) announced Friday new analyses from the Phase 3 Clarity AD study...

Logo PR Newswire
HealthPress Release2023-03-31 13:00:00
KELOWNA, British Columbia, March 31, 2023 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) ("Doseology" or the "Company"), a...

Logo PR Newswire
HealthPress Release2023-03-31 20:30:00
VANCOUVER, BC, March 31, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural...

Logo BBC
WorldBy Https://Www Facebook Com/Bbcnews2023-03-31 22:03:42
By Bernd Debusmann Jr BBC News, Washington Authorities say seven US health investigators fell ill while probing the impact of the 3 February train derailment...

Logo GlobeNewswire
SciencePress Release2023-03-31 12:30:00
Completed Enrollment in INOpulse REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023 Signed License Agreement with Baylor BioSciences to...

Logo PR Newswire
HealthPress Release2023-03-31 03:31:00
PUNE, India, March 31, 2023 /PRNewswire/ -- Team of doctors at Sahyadri Hospitals led by Consultant Cardiologist Dr. Abhijit Palshikar performed a zero...

Logo GlobeNewswire
SciencePress Release2023-03-31 11:00:00
IND application cleared within 6 months of in-licensing CABA-201 binder CABA-201 data package and experience from prior autoimmune cell therapy INDs informed...